Zobrazeno 1 - 10
of 225
pro vyhledávání: '"ARTIFICIAL TRANSCRIPTION FACTORS"'
Autor:
Duško Lainšček, Anja Golob-Urbanc, Veronika Mikolič, Jelica Pantović-Žalig, Špela Malenšek, Roman Jerala
Publikováno v:
Molecular Therapy: Oncolytics, Vol 29, Iss , Pp 77-90 (2023)
CAR-T cells present a highly effective therapeutic option for several malignant diseases, based on their ability to recognize the selected tumor surface marker in an MHC-independent manner. This triggers cell activation and cytokine production, resul
Externí odkaz:
https://doaj.org/article/58eb7d12412e46ef89b62bc6107018b9
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
Due to the high resistance that cancer has shown to conventional therapies, it is difficult to treat this disease, particularly in advanced stages. In recent decades, treatments have been improved, being more specific according to the characteristics
Externí odkaz:
https://doaj.org/article/594b6ae174ac4039830dba882f647764
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 8 (2020)
Filamentous fungal strains of Trichoderma reesei have been widely used for cellulase production, and great effort has been devoted to enhancing their cellulase titers for the economic biorefinery of lignocellulosic biomass. In our previous studies, a
Externí odkaz:
https://doaj.org/article/5e36a90d3712482f99869229e4314b96
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2021)
Frontiers in Oncology, Vol 10 (2021)
Due to the high resistance that cancer has shown to conventional therapies, it is difficult to treat this disease, particularly in advanced stages. In recent decades, treatments have been improved, being more specific according to the characteristics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5317f29b9ab40c591f732b3f509b72f6
https://doi.org/10.3389/fonc.2020.604948
https://doi.org/10.3389/fonc.2020.604948
Publikováno v:
Current neuropharmacology, vol 19, iss 12
Advancements in programmable DNA-Binding Proteins (DBDs) that target the genome, such as zinc fingers, transcription activator-like effectors, and Cas9, have broadened drug target design beyond traditional protein substrates. Effective delivery metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c543f14e969bc2e43395cdcefbfcd9b0
https://escholarship.org/uc/item/55b3z3rz
https://escholarship.org/uc/item/55b3z3rz
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 2, Iss C (2013)
The ability to direct human telomerase reverse transcriptase (hTERT) expression through either genetic control or tunable regulatory factors would advance not only our understanding of the transcriptional regulation of this gene, but also potentially
Externí odkaz:
https://doaj.org/article/fc67d7e6858841718fc61a6338be145d
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 8 (2020)
Filamentous fungal strains of Trichoderma reesei have been widely used for cellulase production, and great effort has been devoted to enhancing their cellulase titers for the economic biorefinery of lignocellulosic biomass. In our previous studies, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb0d648ed7cd3f1576c61edbb84dfaa7
Publikováno v:
Pharmacology & Therapeutics. 182:1-14
Chronic obstructive pulmonary disease (COPD) is an age and smoking related progressive, pulmonary disorder presenting with poorly reversible airflow limitation as a result of chronic bronchitis and emphysema. The prevalence, disease burden for the in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___01423::dd0f26cdfe5c3b05582da111c7fab9d0
https://doi.org/10.1016/j.pharmthera.2017.08.007
https://doi.org/10.1016/j.pharmthera.2017.08.007